Protalix BioTherapeutics
PLX
#7956
Rank
HK$1.75 B
Marketcap
HK$21.76
Share price
-1.58%
Change (1 day)
131.61%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): HK$0.78

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is HK$0.78. In 2022 the company made an earnings per share (EPS) of -HK$2.33 an increase over its 2021 EPS that were of -HK$4.81.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$0.78-133.71%
2022-HK$2.33-51.61%
2021-HK$4.81342.86%
2020-HK$1.09-88.71%
2019-HK$9.62-34.74%
2018-HK$14.74-70.92%
2017-HK$50.692153.35%
2016-HK$2.25-146.77%
2015HK$4.81-287.88%
2014-HK$2.5610%
2013-HK$2.33130.77%
2012-HK$1.01-56.67%
2011-HK$2.33-46.43%
2010-HK$4.3436.59%
2009-HK$3.1832.26%
2008-HK$2.40-93.4%
2007-HK$36.461298.53%
2006-HK$2.61-96.59%
2005-HK$76.4819.32%
2004-HK$64.101552.65%
2003-HK$3.88-0%
2002-HK$3.88-50%
2001-HK$7.76233.33%
2000-HK$2.33-84.21%
1999-HK$14.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$4.96-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$15.20 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.43 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$15.51-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel